Cyclophosphamide eradicates murine immunogenic tumor coding for a non-self-antigen and induces antitumor immunity

Although the majority of cancers respond to chemotherapy, most cancer types relapse, at least in part, due to the poor immunogenicity of most tumor. We have reported before that treatment of tumor bearing mice with a combination of the anti-cancer chemotherapy cyclophosphamide (CTX) and immunotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Salem, Mohamed L, El-Naggar, Sabry A, Mahmoud, Heba A, Elgharabawy, Rehab M, Bader, Abeer M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168726/
https://www.ncbi.nlm.nih.gov/pubmed/30270681
http://dx.doi.org/10.1177/2058738418796591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168726/
https://www.ncbi.nlm.nih.gov/pubmed/30270681
http://dx.doi.org/10.1177/2058738418796591

Ejemplares similares